The full content of Annals is available to subscribers

Subscribe/Learn More  >
Letters |

Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension

Robert Voswinckel, MD; Hossein A. Ghofrani, MD; Friedrich Grimminger, MD; Werner Seeger, MD; and Horst Olschewski, MD
[+] Article, Author, and Disclosure Information

From the University of Giessen Lung Center, 35392 Giessen, Germany, and Medical University Graz, 8036 Graz, Austria.

Potential Financial Conflicts of Interest: Consultancies: H.A. Ghofrani (LungRX), W. Seeger (LungRX), H. Olschewski (LungRX); Honoraria: H.A. Ghofrani (LungRX); Grants received: W. Seeger (LungRX).

Ann Intern Med. 2006;144(2):149-150. doi:10.7326/0003-4819-144-2-200601170-00026
Text Size: A A A


Grahic Jump Location
Acute hemodynamic response of a patient with idiopathic pulmonary arterial hypertension to the inhalation of nitric oxide (20 parts per million) and 15 µg of treprostinil.top, squarestop, circlesbottom, squaresbottom, circles

Asterisks indicate administration of nitric oxide, and daggers indicate administration of treprostinil. Pulmonary artery pressure was substantially reduced with nitric oxide and even further reduced with treprostinil ( ). Systemic arterial pressure was not affected by either substance ( ). Pulmonary vascular resistance was substantially reduced with nitric oxide and even further reduced with treprostinil; the effect of treprostinil outlasted the observation time of 180 minutes ( ). Long-lasting improvement of mixed venous oxygen saturation represented improved cardiac output in absence of gas exchange deterioration ( ).

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.